Achievement of goal resting heart rate on b-blockers in patients with stable angina and hypertension - Athena
Study identifier:NIS-CRU-ATC-2011/1
ClinicalTrials.gov identifier:N/A
EudraCT identifier:N/A
CTIS identifier:N/A
Study Complete
Official Title
Observational non-interventional study – epidemiological survey “AchievemenT of goal resting HEart rate on beta-blockers in patients with stable angiNA and hypertension in routine practice"
Medical condition
Stable Angina
Phase
-
Healthy volunteers
No
Study drug
-
Sex
All
Actual Enrollment
400
Study type
Observational
Age
18 Years +
Date
Study Start Date: 01 Apr 2011
Primary Completion Date: 01 Aug 2011
Study Completion Date: 01 Aug 2011
Study design
Allocation: -
Endpoint Classification: -
Intervention Model: -
Masking: -
Primary Purpose: -
Verification:
Verified 01 Jan 2015 by AstraZeneca Pharmaceuticals
Sponsors
AstraZeneca Pharmaceuticals
Collaborators
-
Inclusion and exclusion criteria
Loading...
No locations available
| Arms | Assigned Interventions |
|---|---|
| achieving resting HR goals Patient population will be comprised of typical for cardiological practice sample of patients with Coronary Heart Disease and arterial hypertension administered beta-blockers, subjects achieving resting HR goals, according to ACC/AHA/ACP-ASIM Guidelines | - |
| non-achieving HR goals Patient population will be comprised of typical for cardiological practice sample of patients with Coronary Heart Disease and arterial hypertension administered beta-blockers, subjects non-achieving HR goals, according to ACC/AHA/ACP-ASIM Guidelines | - |
Contacts
Investigators
Principal Investigator
Alexey Stepanov
AstraZeneca
